Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions

International Journal of Cardiovascular Imaging

Volumn 26, Issue 6, 2010, Pages 693-699

  Śpiewak, Mateusz ^a   Małek, Łukasz A ^a   Chojnowska, Lidia ^a   Miśko, Jolanta ^a   Petryka, Joanna ^a   Kłopotowski, Mariusz ^a   Milosz, Barbara ^a   Polańska, Magdalena ^a   Rużyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Arrhythmia; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Magnetic resonance imaging

Indexed keywords

GADOBUTROL; GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CARDIAC IMAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; AGED; COMPUTER ASSISTED DIAGNOSIS; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POLAND; PREDICTION AND FORECASTING;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; FIBROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; POLAND; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77957942892     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-010-9620-5     Document Type: Article

References (11)

1. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561-1567 (Pubitemid 36543376)
2. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260-2264 (Pubitemid 38757595)
3. Papavassiliu T, Schnabel P, Schröder M, Borggrefe M (2005) CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26:2395 (Pubitemid 41552968)
4. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY (2006) Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114:32-39 (Pubitemid 44305272)
5. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC (2007) Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115:2006-2014 (Pubitemid 46625951)
6. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369-1374 (Pubitemid 351443083)
7. Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS (2008) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24:77-83. Discussion 85-87 (Pubitemid 350263107)
8. Spiewak M, Malek LA, Misko J, Chojnowska L, Milosz B, Klopotowski M, Petryka J, Dabrowski M, Kepka C, Ruzyllo W (2009) Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol. doi:10.1016/j.ejrad.2009.05.035
9. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED, American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, European Society of Cardiology Committee for Practice Guidelines. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy (2003) A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24:1965-1991
10. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A (2004) Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22:155-161 (Pubitemid 38326634)
11. Kwon DH, Setser RM, Popovic ZB, Thamilarasan M, Sola S, Schoenhagen P, Garcia MJ, Flamm SD, Lever HM, Desai MY (2008) Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 24:617-625